Laboratory approaches in desensitization for ABO-incompatible transplantation
Clinical Transplantation and Research · 30.09.2025 · 39 (3) · 250-258
DOI: 10.4285/ctr.25.0041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Transplantation and Research, online erschienen am 05.09.2025. Verfasst von Kyung-Hwa Shin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
ABO-incompatible transplantation, once considered contraindicated due to the risk of hyperacute rejection, has become a viable option owing to advances in immunosuppression and desensitization methods. Accurate measurement and effective reduction of anti-ABO isoagglutinin titers are essential for the success of ABO-incompatible transplantation. This review summarizes the principles of hemagglutination and the measurement of isoagglutinin titers, highlighting variables that influence agglutination sensitivity. The clinical significance of isoagglutinin rebound and its association with rejection risk are also discussed, along with ongoing efforts toward laboratory standardization. Antibody-mediated rejection (AMR) is strongly linked to high pretransplant isoagglutinin titers (≥1:32). Posttransplant isoagglutinin rebound-an important risk factor for AMR-requires careful monitoring in liver and kidney transplant recipients with high initial titers. Desensitization strategies include rituximab, plasmapheresis, intravenous immunoglobulin, bortezomib, and emerging agents such as tocilizumab and imlifidase. This review aims to enhance understanding of the immunological and laboratory aspects of ABO-incompatible transplantation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
- Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
ORCID-Profile: Kyung-Hwa Shin, Hyun-Ji Lee
Zitieren
APA
Shin, K. H., & Lee, H. J. (2025). Laboratory approaches in desensitization for ABO-incompatible transplantation. Clinical Transplantation and Research, 39(3), 250-258. https://doi.org/10.4285/ctr.25.0041
Vancouver
Shin KH, Lee HJ. Laboratory approaches in desensitization for ABO-incompatible transplantation. Clinical Transplantation and Research. 2025;39(3):250-258. doi:10.4285/ctr.25.0041
BibTeX
@article{Shin2025,
author = {Shin, Kyung-Hwa and Lee, Hyun-Ji},
title = {Laboratory approaches in desensitization for ABO-incompatible transplantation},
journal = {Clinical Transplantation and Research},
year = {2025},
volume = {39},
number = {3},
pages = {250--258},
doi = {10.4285/ctr.25.0041}
}
EUVIMED